Article
Differential signature of fecal microRNAs in patients with pancreatic cancer
10 Apr 2012
Abstract excerpt
The potential value of microRNAs as new biomarkers for pancreatic cancer (PCa) screening was explored in this study. Fecal microRNAs from stool samples obtained from 29 PCa patients, 22 chronic pancreatitis (CP) patients and 13 normal individuals were extracted, and 7 microRNAs (miR-16, miR-21, miR-155, miR-181a, miR-181b, miR-196a and miR-210) were detected. miR-181b and miR-210 discriminated PCa from normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
